Spelling suggestions: "subject:"eprescription"" "subject:"déprescription""
71 |
An Examination Of Adult Age Differences In Implicit And Explicit Memory For Prescription Drug AdvertisementsAbernathy, L Ty 13 December 2008 (has links)
Prescription drug advertisements are commonly seen in magazines and on television, and as a result, the public is familiar with them. Many drug ads are targeted toward older adults, who tend to use more medications, because they suffer from more chronic conditions than younger adults. Nonetheless, the effectiveness of drug advertising at persuading older adults to ask physicians for specific medications remains uncertain. Older adults’ explicit memory for drug ads is poor, but their implicit memory for drug ads may be better. Therefore, older adults may be implicitly persuaded by drug ads even when they cannot explicitly remember seeing them. The current study measured implicit memory with an incidental ratings exercise and an indirect test of preference; explicit memory was measured with intentional studying and a direct test of recognition. The purposes of the study were to compare implicit and explicit memory for drug ads in older and younger adults, to determine whether age differences in memory are affected by salient information or anxiety, and to demonstrate that a test of implicit memory may be useful in estimating advertising effectiveness. The results showed no age difference for implicit memory for drug ads, but an age difference was found for explicit memory for drug ads. However, contrary to hypotheses, neither salient information nor anxiety had an effect on implicit or explicit memory. The results were consistent with previous research demonstrating implicit memory in the absence of explicit memory. Although older adults had slightly worse explicit memory, both implicit and explicit memory for drug ads was generally good in both groups. The results were also obtained within the everyday context of prescription drug advertising, which extends memory research to an important real-world setting. Ethical considerations for research on aging and advertising are discussed. Drug ads are designed to be persuasive, but ads should be carefully designed to inform consumers, rather than to manipulate them. The implicit memory manipulation succeeded in demonstrating that ads are persuasive, suggesting that a complete assessment of advertising effectiveness should include a test of implicit memory.
|
72 |
An Evaluation of the Impact of Cue Exposure on the Relationship Between Pain Level and Craving For Prescription OpiodsAshrafioun, Lisham 09 June 2014 (has links)
No description available.
|
73 |
College Students' Perceptions of Prescription and Non-Prescription Drug UseGallagher, Lisa A. 04 June 2018 (has links)
No description available.
|
74 |
Drug ingredient acquisition cost determination for third-party prescription drug programs /Wadelin, Jeffrey W. January 1986 (has links)
No description available.
|
75 |
Impact des activités du pharmacien sur la qualité de la pharmacothérapie des patients ayant des besoins complexes suivis en GMF-UMFSamir Abdin, Madjda 24 May 2018 (has links)
Récemment, des rehaussements en ressources humaines professionnelles, dont les pharmaciens, ont eu lieu au sein de plusieurs Groupes et Unités de Médecine de Famille (GMF-UMF) du Québec. Notre objectif est de mesurer l'impact des interventions des pharmaciens sur la pharmacothérapie des patients ayant des besoins complexes suivis dans les GMF-UMF. Les problèmes liés à la pharmacothérapie (PRP), la complexité du régime médicamenteux et l’adhésion au traitement chez les patients ayant des besoins complexes référés par leur médecin, ont été comparés avant et après les interventions du pharmacien dans quatre GMF-UMF à Québec. Les PRP identifiés ont été regroupés et décrits en utilisant la classification de Strand. La complexité du régime médicamenteux a été mesurée en utilisant l'indice de complexité du régime médicamenteux (MRCI) tandis qu’on a mesuré l’adhésion à l’aide de la proportion de jours couverts (PDC) en se basant sur l'information du bilan comparatif des médicaments (BCM). Les moyennes des MRCI et des PDC, avant et après les interventions des pharmaciens, ont été comparées par un test-t sur échantillons appariés. Dans cette étude, 92 patients ont été référés aux pharmaciens, dont 64 ont été sélectionnés suivant les critères d’inclusion, parmi lesquels, 56 patients ayant 2 BCM ont été inclus dans l’analyse. L’échantillon se composait majoritairement de femmes âgées ayant de multiples comorbidités, une polypharmacie et un régime médicamenteux complexe. Le pharmacien détectait en moyenne 7,2 PRP par patient. Ses interventions ont mené à une diminution de la complexité du régime médicamenteux (différence des moyennes (DM) de 5,44 au MRCI) et à une augmentation de l’adhésion aux traitements (DM de 5,6 % pour la PDC). Les pharmaciens GMF-UMF ont pu détecter et résoudre les PPR, diminuer la complexité du régime médicamenteux et la non-adhésion aux traitements chez les patients ayant des besoins complexes dans les cliniques de soins de première ligne. / Recently, improvements in professional human resources, including pharmacists, took place within several Family Medicine Groups and Units (FMG-FMU) in Quebec. Our objective, is to measure the impact of pharmacist’ interventions on the pharmacotherapy for patients with complex needs monitored in FMG-FMU in Quebec City. Drug related problems (DRPs), medication regimen complexity and adherence to treatment in patients with complex needs referred by their physician, have been compared before and after the pharmacist' interventions in four FMG-FMU in Quebec City. Identified DRP were grouped and described using Strand classification. The medication regimen complexity was calculated using the medication regimen complexity index (MRCI) while adherence was measured using the proportion of days covered (PDC) based on information of medication reconciliation (MedRec). The MRCI and PDC means, before and after pharmacists’ interventions, were compared with a paired sample t-test. In this study, 92 patients were referred to pharmacists, of whom 64 were selected according to the inclusion criteria, of which 56 patients with 2 MedRec were included in the analysis. The sample consisted mainly of elderly women with multiple comorbidities and suffering from poly-pharmacy and medication regimen complexity. An average of 7.2 PRP / patient was found as well as a decrease in the medication regimen complexity of 5.44 and an increase in adherence to treatment of 5.6%. The FMG-FMU pharmacists could detect and resolve DRPs, decrease medication regimen complexity and non-adherence to treatment in patients with complex needs in primary care clinics.
|
76 |
A user satisfaction study of the NHS Online Prescription Prepayment CertificateIrani, Zahir, Weerakkody, Vishanth J.P., Molnar, A., Lee, Habin, Hindi, N., Osman, I. 06 December 2014 (has links)
No / This research seeks to measure citizen satisfaction with the electronic Prescription Prepayment Certificate (PPC) offered by National Health Service (NHS) in the United Kingdom (UK). The paper reports on the findings of a survey of over 500 users of the NHS PPC service. Satisfaction is measured using the four dimensions from the COBRA framework (Osman et al. (2011) [1]) which comprise the cost, opportunity, benefits and risk assessment constructs. This is the first study to measure citizen satisfaction with the electronic PPC in the UK across these constructs. The results show that most citizens using the PPC electronic service are satisfied with this service and that the service meets their essential needs. The paper also presents the results of qualitative feedback obtained from the participants that can be used to determine the areas that need further improvement in the current electronic PPC service and potential influence on user satisfaction.
|
77 |
Patients' and nurses' perspectives on patients' experience for coronary care unit stressors using a mixed method approachQaid, Rafa T. A. January 2011 (has links)
Background: Getting admitted to CCU is viewed as a stressful event by patients. However, numerous studies have indicated that nurses do not always accurately perceive the stressors of their clients. Therefore, it is important for nurses to know what seems most stressful from the patients‘ perspective so that appropriate nursing measures can be directed towards minimizing such stressors. Objectives: The purpose of this study was to explore the perception of CCU stressors experienced by patients from both patients and nurses perspective and to compare between them, identify the effect of socio-demographic characteristics of participant's on the level of stress perception and to what extent clinical guidelines fulfil CCU needs. Methodology: A mixed method approach (qualitative and quantitative) was applied. Purposive random sampling was used to recruit data. Ethical approval was obtained prior to data collection. Data was collected from three CCUs within the West and Northwest NHS Trusts. Participants who met the inclusion criteria were interviewed and asked to rank the Environmental Stressor Questionnaire (ESQ). Qualitative data was analyzed using Gorgi's method of analysis. A quantitative data was analyzed using the SPSS software version 15. Results: There was some consistency in the data where patients and nurses provided same ranking for CCU stressors. Consistently nurses ranked physiological stressors higher than psychological stressors. Patients showed consistency in the findings between what they ranked in the ESQ and their narratives more than their counterparts. Perception of stress was affected by participant's socio-demographic characteristics. A key finding is that the current guidelines do not serve patients and nurses needs. Conclusions: Nurses should be well equipped with knowledge and experience to overcome stressful situations. Educational programs should be made available for nurses to improve stress management. Nurses should assess patient's needs by applying effectively communication skills.
|
78 |
La persistance des traitements en vie réelle comme mesure d'impact en pharmco-épidémiologie / Persistence of treatment as an outcome in pharmacepidemiologyDroz-Perroteau, Cécile 19 December 2012 (has links)
En pharmaco-épidémiologie, les études visant à évaluer l’impact des médicaments sur la santé de la population en situation réelle d’utilisation à la demande des Autorités de Santé en France, sont conduites dans un contexte contraint, en l’absence de bases de données médicalisées populationnelle. Le choix des critères d’évaluation des études de terrain à mener est donc crucial. Les critères directs de mesure d’impact (mortalité, morbidité, qualité de vie) sont parfois complexes à obtenir à large échelle, aussi, l’utilisation de critères indirects est souvent nécessaire. La persistance des traitements est un critère combinant de nombreux avantages : reflet de la pratique médicale courante et simplicité de recueil. Dans le cadre de cette thèse, nous avons proposé d’étudier l’intérêt de la persistance des traitements comme critère de mesure d’impact, angle peu exploré jusque là, la persistance étant usuellement considérée comme paramètre d’exposition. Aussi, dans le Chapitre 1, nous avons précisé à quels niveaux la persistance des traitements entre dans le champ de l’évaluation de l’impact. Puis, à partir de trois études de terrain, nous avons évalué l’intérêt de la mesure de la persistance au sein de deux niveaux d’impact. La persistance comme mesure directe de l’utilisation et du respect des recommandations est illustrée dans le Chapitre 2 (prévention secondaire du post-infarctus du myocarde). La persistance comme mesure indirecte de l’efficacité en vie réelle est illustrée : dans le Chapitre 3 où la persistance signe l’échec thérapeutique (traitement curatif de la sinusite aigue) puis dans le Chapitre 4 où la persistance est considérée comme un succès thérapeutique (traitement suspensif de l’épilepsie). Pour finir, nous avons discuté l’intérêt des résultats issus de ces travaux au regard du contexte actuel des demandes d’étude requises par les Autorités de Santé avec la perspective de la mise en place de la nouvelle législation européenne d’évaluation du médicament. / Pharmacoepidemiological studies requested by French Health Authorities to assess impact of treatment in real-life medical practice are performed in a restricted context, in the absence of a national health care databases. The choice of evaluation criteria for field studies is thus crucial. Direct impact measure criteria (mortality, morbidity, quality of life) are sometimes difficult to obtain on a large scale, therefore, the use of indirect criteria is often required. Treatment persistence is a criterion that combines several advantages: reflection of real-life medical practice and ease of collection. In this thesis, we studied persistence of treatment as a measure of impact, an original point of view as persistence is usually considered as a parameter of exposure. In Chapter 1, we have detailed at which level persistence of treatment is part of the field of impact evaluation. Thereafter, using three field studies, we assessed measure of persistence within two aspects of impact. Persistence as a direct measure of use and respect of recommendations is illustrated in Chapter 2 (secondary prevention in post-myocardial infarction). Persistence as an indirect measure of effectiveness is illustrated: in Chapter 3 where persistence is a sign of treatment failure (curative treatment of acute sinusitis) then in Chapter 4 where persistence is considered as treatment success (long-term treatment in epilepsy). In conclusion, we have discussed the results of this work with regards to the current context of studies requested by Health Authorities and with the forthcoming implementation of new European pharmacovigilance legislation.
|
79 |
Medical prescriptions in Cyprus.Papadopoulos, Philippos January 2014 (has links)
MEDICAL PRESCRIPTIONS IN CYPRUS Author: Papadopoulos V. Philippos Tutor: RNDr. Jana Kotlářová, Ph.D. Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Czech Republic Aim of diploma thesis is to get: current knowledge about medical prescriptions (MP) in Cyprus and rules of their use their basic division according their kinds, formal look, practical handle, payment knowledge of the current Health system of Cyprus Results: The Health system of Cyprus is a unique arrangement in the EU since is a simultaneous participation of public and the private sector which has many phenomena of inequality and non- accessibility mainly from the economically weaker. In the future plans of Ministry of Health is the complete redesign of entire Health System in a direction of electronic services for all the parts of health system chain including doctors, pharmacists and insured patients. The basic and significant informations about medical prescriptions in Cyprus according aim of diploma thesis are demonstrated in the Summary Table at chapter 11. All prescriptions in Cyprus are in common form for all type of drugs and there is no rule for size and color of the paper. Pharmacist is checking the signature of the doctor as well as name of the patient and...
|
80 |
Medical prescriptions in GreeceNaoum, Panagiotis January 2014 (has links)
MEDICAL PRESCRIPTIONS IN GREECE Author: Naoum I. Panagiotis Tutor: RNDr. Jana Kotlářová, Ph.D. Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Czech Republic Aim of diploma thesis: The aim of diploma thesis is: to get current knowledge about medical prescriptions (MP) in Greece and rules of their use; to prepare its basic division according their kinds, formal look, practical handle with them and their payment; to get sample of different MP and finally to describe the current Greek health, pension and insurance system as a secondary aim. Results: In this diploma thesis it has been described the existing model of medical prescriptions in Greece and have been given adequate information about their basic divisions, their kinds, their formal look, and their compensation. Also it is described the course of the prescription, from the doctor to the pharmacist, harmonized with modern electronic prescribing. In the recent years (from 2009), Greece started the pilot implementation of e-prescribing for the modernization of public administration. This reform was established in order to fight against impunity and seemingly anti-ethical actions. The measure was certified by the laws of the Greek State, whereas the first results are starting to show...
|
Page generated in 0.5531 seconds